CDER - Office of Pharmaceutical Science - Organization - Text version
The following header reflects the organizational hierarchy.
FOOD AND DRUG ADMINISTRATION
OFFICE OF MEDICAL PRODUCTS AND TOBACCO
CENTER FOR DRUG EVALUATION AND RESEARCH
OFFICE OF PHARMACEUTICAL SCIENCE
The following is the communication box containing information to assist anyone who may want to communicate with the depicted organization via telephone, facsimile or mail.
WO Bldg 51 Rm: 4184
10903 New Hampshire Ave.
Silver Spring, MD 20993
The following is the Food and Drug Administration’s, Office of Medical Products and Tobacco, Center for Drug Evaluation and Research, Office of Pharmaceutical Science organization structure depicting all the organizational structures reporting to the Office Director. These organizational structures are organized in sequential order by their assigned Standard Administrative code (Alphanumeric sequence of characters beginning with the letter D).
Each organizational component will be depicted in the following standard format:
Title of organization.
Position title of the manager.
Military rank if any, first name, middle initial if any, last name, post graduate degrees if any, and if the individual is designated as acting.
Standard Administrative code.
Keith Webber, Ph.D. (Acting)
Reports directly to the Office Director:
Lawrence Yu (Acting)
OFFICE OF GENERIC DRUGS
Kathleen Uhl, M.D. (Acting)
Robert West, R.Ph.
OFFICE OF NEW DRUG QUALITY ASSESSMENT
Christine Moore, Ph.D. (Acting)
Deputy Director Review and Operations
Elaine Morefield, Ph.D.
Deputy Director Science and Policy
Richard Lostritto, Ph.D. (Acting)
OFFICE OF TESTING AND RESEARCH
Lucinda Buhse, Ph.D. (Acting)
OFFICE OF BIOTECHNOLOGY PRODUCTS
Steven Kozlowski, M.D.
Jeffrey Baker, Ph.D.
Approved by the FDA Reorganization Coordinator and Principal Delegations Control Officer